Genomics Market - 2026-2033

April 2026 | 34 pages | ID: G598D1699469EN
DataM Intelligence

Abstracts

Genomics Marketis is growing with a CAGR of 18.70% during the forecast period 2026-2035.

The Genomics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Genomics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Application & Technology

• Functional Genomics *
• Transfection
• Real-Time PCR
• RNA Interference
• Mutational Analysis
• SNP Analysis
• Microarray Analysis
• Epigenomics
• Bisulfite Sequencing
• Chromatin Immunoprecipitation (CHIP & CHIP-Seq)
• Methylated DNA Immunoprecipitation (MEDIP)
• High-Resolution Melt (HRM)
• Chromatin Accessibility Assays
• Pathway Analysis
• Bead-Based Analysis
• Proteomics Tools
• Biomarker Discovery
• Mass Spectrometry
• Statistical Analysis
• Bioinformatics
• DNA Sequencing
• Others

By Products and Services

• Products *
• Instruments/Systems/Software
• Consumables & Reagents
• Services
• NGS-Based Services
• Core Genomics Services
• Biomarker Translation Services
• Computational Services
• Others

By End-User

• Clinical Research
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Regional Analysis for Genomics Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Genomics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Application & Technology
3.2. Snippet by Products and Services
3.3. Snippet by End-User
3.4. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Adoption of Genomics in Pharmaceutical Developments
    4.1.1.2. Increasing Demand for Genomic Testing and Analysis
  4.1.2. Restraints
    4.1.2.1. Stringent Regulatory Challenges
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine Conflict Analysis
5.6. DMI Opinion

6. BY APPLICATION & TECHNOLOGY

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  6.1.2. Market Attractiveness Index, By Application & Technology
6.2. Functional Genomics *
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  6.2.3. Transfection
  6.2.4. Real-Time PCR
  6.2.5. RNA Interference
  6.2.6. Mutational Analysis
  6.2.7. SNP Analysis
  6.2.8. Microarray Analysis
6.3. Epigenomics
  6.3.1. Bisulfite Sequencing
  6.3.2. Chromatin Immunoprecipitation (CHIP & CHIP-Seq)
  6.3.3. Methylated DNA Immunoprecipitation (MEDIP)
  6.3.4. High-Resolution Melt (HRM)
  6.3.5. Chromatin Accessibility Assays
  6.3.6. Microarray Analysis
6.4. Pathway Analysis
  6.4.1. Bead-Based Analysis
  6.4.2. Microarray Analysis
  6.4.3. Real-Time PCR
  6.4.4. Proteomics Tools
6.5. Biomarker Discovery
  6.5.1. Mass Spectrometry
  6.5.2. Real-Time PCR
  6.5.3. Microarray Analysis
  6.5.4. Statistical Analysis
  6.5.5. Bioinformatics
  6.5.6. DNA Sequencing
6.6. Others

7. BY PRODUCTS AND SERVICES

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  7.1.2. Market Attractiveness Index, By Products and Services
7.2. Products *
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Instruments/Systems/Software
  7.2.4. Consumables & Reagents
7.3. Services
  7.3.1. NGS-Based Services
  7.3.2. Introduction
  7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Core Genomics Services
7.5. Biomarker Translation Services
7.6. Computational Services
7.7. Others

8. BY END-USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  8.1.2. Market Attractiveness Index, By End-User
8.2. Clinical Research
8.3. Academic & Government Institutes
  8.3.1. Introduction
  8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Hospitals & Clinics
8.5. Pharmaceutical & Biotechnology Companies
8.6. Others

9. BY REGION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.6.1. U.S.
    9.2.6.2. Canada
    9.2.6.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.6.1. Germany
    9.3.6.2. UK
    9.3.6.3. France
    9.3.6.4. Italy
    9.3.6.5. Russia
    9.3.6.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.6.1. Brazil
    9.4.6.2. Argentina
    9.4.6.3. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.6.1. China
    9.5.6.2. India
    9.5.6.3. Japan
    9.5.6.4. Australia
    9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. COMPETITIVE LANDSCAPE

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. COMPANY PROFILES

11.1. Agilent Technologies *
  11.1.1. Company Overview
  11.1.2. Product Portfolio and Description
  11.1.3. Financial Overview
  11.1.4. Key Developments
11.2. Bio-Rad Laboratories, Inc.
11.3. BGI Genomics
11.4. Color Genomics, Inc
11.5. Danaher Corporation
11.6. Eurofins Scientific
11.7. F. Hoffmann-La Roche Ltd
11.8. GE Healthcare
11.9. Illumina, Inc.
11.10. Myriad Genetics, Inc. (*LIST NOT EXHAUSTIVE)

12. APPENDIX

12.1. About Us and Services
12.2. Contact Us